1. Heparin is the first choice for rapid anticoagulation, which can be used for surgical thrombosis prevention and anticoagulation treatment in pregnant women. In patients with acute myocardial infarction, heparin can be used to prevent venous thromboembolism and to prevent arterial embolism in patients with large anterior transmural myocardial infarction.
2. Another important clinical application of heparin is to maintain cardiopulmonary bypass during cardiac, surgical, and renal dialysis.
3. Used for the treatment of various causes of diffuse intravascular coagulation, can also be used for the treatment of glomerulonephritis, nephrotic syndrome, rheumatoid arthritis, etc.
Heparins Manufacturer describes the initial clinical use of heparin, common heparin, or common heparin, primarily for anticoagulant and antithrombotic therapy, for diffuse intravascular coagulation and antithrombotic therapy due to a variety of causes, as well as anticoagulant therapy such as hemodialysis, cardiopulmonary bypass, catheterization, and microvascular surgery. At the same time, clinical application and research show that standard heparin has anti-inflammatory, anti-allergy, hypolipidemic, anti-arteriosclerosis, anti-vascular smooth muscle cell proliferation, anti-virus, anti-cancer and other biological activities and clinical applications.
Low molecular weight heparin: To reduce the side effects of heparin, such as bleeding, thrombocytopenia and osteoporosis, low molecular weight heparin was first developed in Europe in the late 1980s. A large number of clinical studies have confirmed that low molecular weight heparin has the advantages of strong antithrombotic effect and small side effects, and has a wider range of medical applications. It has become the preferred drug for the treatment of acute venous thrombosis and acute coronary syndrome (angina pecina, myocardial infarction). Because heparin has a unique anticoagulant and antithrombotic mechanism by interfering with some aspects of the coagulation process, its clinical application value is still in the process of development. With increasing r&d efforts, heparin will continue to be developed for new indications, which will become an important development space for heparin products in the future.